Cargando…
Self-stigma and schizophrenia: a cross-sectional study
OBJECTIVE: The aim of this study was to investigate the degree of self-stigma in schizophrenia and its association with clinical and demographic factors. PATIENTS AND METHODS: A total of 197 outpatients (54.3% females) diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective d...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127434/ https://www.ncbi.nlm.nih.gov/pubmed/27920538 http://dx.doi.org/10.2147/NDT.S120298 |
_version_ | 1782470245414338560 |
---|---|
author | Vrbova, Kristyna Prasko, Jan Holubova, Michaela Kamaradova, Dana Ociskova, Marie Marackova, Marketa Latalova, Klara Grambal, Ales Slepecky, Milos Zatkova, Marta |
author_facet | Vrbova, Kristyna Prasko, Jan Holubova, Michaela Kamaradova, Dana Ociskova, Marie Marackova, Marketa Latalova, Klara Grambal, Ales Slepecky, Milos Zatkova, Marta |
author_sort | Vrbova, Kristyna |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to investigate the degree of self-stigma in schizophrenia and its association with clinical and demographic factors. PATIENTS AND METHODS: A total of 197 outpatients (54.3% females) diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective disorder, delusional disorder) according to International Classification of Diseases – tenth edition participated in the study. The mean age of the patients was 40.10±11.49 years. All individuals completed the Internalized Stigma of Mental Illness (ISMI) scale and a demographic questionnaire. The disorder severity was assessed by both a psychiatrist (the objective version of Clinical Global Impression – severity scale [objCGI-S]) and the patients (the subjective version of Clinical Global Impression – severity scale [subjCGI-S]). Treatment with antipsychotics stabilized the patients. RESULTS: The overall level of self-stigma measured by the total score of the ISMI was 63.32±13.59. The total score of the ISMI positively correlated with the severity of the disorder measured by the objCGI-S and subjCGI-S. In addition, self-stigma positively correlated with the treatment duration and the number of psychiatric hospitalizations. The backward stepwise regression was applied to identify the most significant factors connected to self-stigma. The regression analysis identified the following regressors as the most relevant to self-stigma: the number of previous psychiatric hospitalizations, the severity of the disorder rated by a psychiatrist, and the difference between the objective rating and the subjective rating of the severity of the disorder. CONCLUSION: Outpatients with schizophrenia spectrum disorders, who have undergone a higher number of psychiatric hospitalizations, who dispose of a higher severity of the disorder and show a higher discrepancy between their rating of the severity and the psychiatric rating, showed a greater degree of self-stigma. The management of self-stigma in patients with schizophrenia should be implemented in the routine care. |
format | Online Article Text |
id | pubmed-5127434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-51274342016-12-05 Self-stigma and schizophrenia: a cross-sectional study Vrbova, Kristyna Prasko, Jan Holubova, Michaela Kamaradova, Dana Ociskova, Marie Marackova, Marketa Latalova, Klara Grambal, Ales Slepecky, Milos Zatkova, Marta Neuropsychiatr Dis Treat Original Research OBJECTIVE: The aim of this study was to investigate the degree of self-stigma in schizophrenia and its association with clinical and demographic factors. PATIENTS AND METHODS: A total of 197 outpatients (54.3% females) diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective disorder, delusional disorder) according to International Classification of Diseases – tenth edition participated in the study. The mean age of the patients was 40.10±11.49 years. All individuals completed the Internalized Stigma of Mental Illness (ISMI) scale and a demographic questionnaire. The disorder severity was assessed by both a psychiatrist (the objective version of Clinical Global Impression – severity scale [objCGI-S]) and the patients (the subjective version of Clinical Global Impression – severity scale [subjCGI-S]). Treatment with antipsychotics stabilized the patients. RESULTS: The overall level of self-stigma measured by the total score of the ISMI was 63.32±13.59. The total score of the ISMI positively correlated with the severity of the disorder measured by the objCGI-S and subjCGI-S. In addition, self-stigma positively correlated with the treatment duration and the number of psychiatric hospitalizations. The backward stepwise regression was applied to identify the most significant factors connected to self-stigma. The regression analysis identified the following regressors as the most relevant to self-stigma: the number of previous psychiatric hospitalizations, the severity of the disorder rated by a psychiatrist, and the difference between the objective rating and the subjective rating of the severity of the disorder. CONCLUSION: Outpatients with schizophrenia spectrum disorders, who have undergone a higher number of psychiatric hospitalizations, who dispose of a higher severity of the disorder and show a higher discrepancy between their rating of the severity and the psychiatric rating, showed a greater degree of self-stigma. The management of self-stigma in patients with schizophrenia should be implemented in the routine care. Dove Medical Press 2016-11-24 /pmc/articles/PMC5127434/ /pubmed/27920538 http://dx.doi.org/10.2147/NDT.S120298 Text en © 2016 Vrbova et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Vrbova, Kristyna Prasko, Jan Holubova, Michaela Kamaradova, Dana Ociskova, Marie Marackova, Marketa Latalova, Klara Grambal, Ales Slepecky, Milos Zatkova, Marta Self-stigma and schizophrenia: a cross-sectional study |
title | Self-stigma and schizophrenia: a cross-sectional study |
title_full | Self-stigma and schizophrenia: a cross-sectional study |
title_fullStr | Self-stigma and schizophrenia: a cross-sectional study |
title_full_unstemmed | Self-stigma and schizophrenia: a cross-sectional study |
title_short | Self-stigma and schizophrenia: a cross-sectional study |
title_sort | self-stigma and schizophrenia: a cross-sectional study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127434/ https://www.ncbi.nlm.nih.gov/pubmed/27920538 http://dx.doi.org/10.2147/NDT.S120298 |
work_keys_str_mv | AT vrbovakristyna selfstigmaandschizophreniaacrosssectionalstudy AT praskojan selfstigmaandschizophreniaacrosssectionalstudy AT holubovamichaela selfstigmaandschizophreniaacrosssectionalstudy AT kamaradovadana selfstigmaandschizophreniaacrosssectionalstudy AT ociskovamarie selfstigmaandschizophreniaacrosssectionalstudy AT marackovamarketa selfstigmaandschizophreniaacrosssectionalstudy AT latalovaklara selfstigmaandschizophreniaacrosssectionalstudy AT grambalales selfstigmaandschizophreniaacrosssectionalstudy AT slepeckymilos selfstigmaandschizophreniaacrosssectionalstudy AT zatkovamarta selfstigmaandschizophreniaacrosssectionalstudy |